A subset of melanoma cells displays diminished antigen-presenting capacity, including the downregulation of major histocompatibility complex (MHC) class I and II molecules and essential proteins required for the adequate functioning of the MHC, such as the transporter associated with antigen processing protein (TAP) [41,50,51,52]. Here, HLA-C is linked to melanoma.